Orexigen Therapeutics, Inc.
NASDAQ: OREX
$0.22
Closing price April 3, 2018
These are the top Wall Street analyst upgrades, downgrades and initiations for Thursday, June 12, 2014. They include Apache, Apple, Hewlett-Packard, Qualcomm and Sprouts Farmers Market.
Published:
VIVUS Inc. (NASDAQ: VVUS) investors have a lot to be disappointed about these days. America’s ballooning waistline is reaching a critical level, yet VIVUS did not even manage to close up one...
Published:
Once again, the analysts at Piper Jaffray are conducting extensive management meetings with the companies they cover. Here are the seven top biopharma stocks to buy now, according to Piper Jaffray.
Published:
The Cowen biotechnology team has a list of top 10 surprises that are specific to the very hot biotechnology sector.
Published:
With the government shut down and with the debt ceiling debate breathing down everyone’s neck, investors have to be wondering what they should buy, sell and hold (or even avoid). Stocks have...
Published:
As a rule, Wall Street brokers and financial advisors typically try to steer their clients away from stocks that trade under $10, as well as avoid like the plague stocks that trade under $5. There...
Published:
Last Updated:
The higher the market climbs, the harder it becomes for investors to find solid stock ideas to add or scale in to their portfolios. With the market currently teetering on what seems like an...
Published:
Last Updated:
Drug maker Arena Pharmaceuticals Inc. (NASDAQ: ARNA) has withdrawn its application for European regulatory approval of its weight-loss drug Belviq. The drug was approved for use in the United States...
Published:
Last Updated:
Much of the research coverage on Wall St. from the bulge bracket firms is concentrated on the most liquid, best known stocks from the S&P 500. These names are recognizable to investors and are...
Published:
VIVUS Inc. (NASDAQ: VVUS) reported a quarterly loss of $0.56 per share on Monday, but this was not an earnings story. VIVUS remains a developing story about its obesity drug Qsymia. Its revenue came...
Published:
If you are obese in Europe, you are not about to get a little pill to take to help you change. You will just have to lose that weight the old-fashioned way through diet, exercise, and lifestyle...
Published:
According to the Centers for Disease Control (CDC), more than one-third (35.7%) of all adults in the United States are obese or very overweight. Obesity-related medical conditions include heart...
Published:
Last Updated:
Arena Pharmaceuticals Inc. (NASDAQ: ARNA) is posing yet one more threat to ambitious biotechs and drug-makers who are targeting the obesity market. Its stock is getting slapped by almost 10% on news...
Published:
Back in December, we took an in-depth look at what has become a crowded race in the obesity drug market. As we pointed out then, the race has become a battle of not only who has the drug with the...
Published:
Last Updated:
According to the Centers for Disease Control (CDC), more than one-third (35.7%) of all adults in the United States are obese. Obesity-related medical conditions include heart attack, stroke, type-2...
Published: